Atezolizumab and Nab-paclitaxel
About
Membership operator: AND
Therapies: 2
Therapies
Atezolizumab (tx:ncit:C106250)
Nab-paclitaxel (tx:ncit:C2688)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy group.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| EMA (1) | ER negative, HER2-negative, PD-L1 >= 1%, PR negative | Invasive Breast Carcinoma | Atezolizumab, Nab-paclitaxel |